NYSE Content Advisory: Pre-Market update + China considering trade negotiations
NEW YORK, May 2, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Kristen Scholer...
Keypoint Intelligence Appoints Mark Boyt as Principal Analyst for Production Workflow Software
FAIRFIELD, N.J., Feb. 26, 2025 /PRNewswire/ -- Keypoint Intelligence is pleased to announce that Mark Boyt has joined the company as Principal Analyst for Production Workflow Software. Boyt brings extensive experience in software marketing, business...
Corti's First AId Report: Burnout levels challenge healthcare professionals' ability to care for patients in Europe and the U.S.
Artificial Intelligence could be a lifeline but unsuccessful trials, limited opportunities, and lack of experience is holding healthcare professionals back Europe lagging behind the U.S. in terms of acceptance and adoption of AI and differences...
Hanmi Pharmaceutical and Beijing Hanmi Progress Clinical Trials of Co-developed BH3120 as a Next-Generation Cancer Immunotherapy
Hanmi unveils tiral in progress poster on BH3120 at the Society for Immunotherapy of Cancer (SITC) in the U.S. Phase 1 trial is progressing smoothly, with no dose-limiting toxicity observed Phase 1 trial evaluating the combination of BH3120 and...